International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,773 | -6,571 | -6,072 | -6,584 | -1,386 |
| Depreciation Amortization | 273 | 1,177 | 136 | 772 | 88 |
| Accounts receivable | -49 | -72 | -10 | N/A | N/A |
| Accounts payable and accrued liabilities | -56 | -514 | 441 | 84 | 13 |
| Other Working Capital | 43 | -687 | 280 | 45 | 2 |
| Other Operating Activity | 2,333 | 1,917 | -4 | 2,330 | -13 |
| Operating Cash Flow | $-5,228 | $-4,750 | $-5,229 | $-3,352 | $-1,296 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -731 | -254 | -431 | -68 | -57 |
| Purchase Sale Intangibles | -159 | -64 | -7 | -1 | -4 |
| Other Investing Activity | -159 | -64 | -7 | -1 | -4 |
| Investing Cash Flow | $-890 | $-318 | $-438 | $-69 | $-61 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,360 | N/A | N/A | 600 |
| Debt Issued | N/A | N/A | N/A | 250 | 780 |
| Common Stock Issued | 1,494 | N/A | 1,373 | 10,382 | N/A |
| Dividend Paid | -331 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 5,300 | 3,925 | -238 | -2,548 | 0 |
| Financing Cash Flow | $6,463 | $5,285 | $1,135 | $8,085 | $1,380 |
| Beginning Cash Position | 382 | 165 | 4,697 | 33 | 10 |
| End Cash Position | 727 | 382 | 165 | 4,697 | 33 |
| Net Cash Flow | $345 | $217 | $-4,531 | $4,663 | $24 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,228 | -4,750 | -5,229 | -3,352 | -1,296 |
| Capital Expenditure | -731 | -254 | -431 | -68 | -57 |
| Free Cash Flow | -5,959 | -5,005 | -5,659 | -3,421 | -1,353 |